Tongxin Zhiyi
AI-powered brain science diagnosis and treatment platform
About Tongxin Zhiyi
Tongxin Zhiyi, which has also been referred to as Sophmind, originated from Tsinghua University's Green Medical Research Institute and operates as a high-tech enterprise within the Tsinghua Science Park. The company focuses on developing an AI-driven platform for brain science diagnostics and treatment, targeting major brain diseases. It integrates AI research, product development, and clinical application to provide comprehensive services for hospitals and physicians.
The company's core offering is its "New Generation AI Brain Science Diagnosis and Treatment Platform." This platform is built upon three pillars: "Sophmind Brain Science" for medical technology R&D, "Sophmind Neosoph" for AI product conversion, and "Sophmind Medical Union" for clinical application. In collaboration with Tsinghua University's computer science department, Tongxin Zhiyi has developed an innovative algorithm that combines causal inference and deep learning to enhance the accuracy and reliability of disease prediction for neurological conditions. Its product pipeline includes over 10 AI-powered analytical tools for brain science, such as intelligent analysis for aneurysms and whole-brain quantification, with several products having received NMPA certification.
The business model combines an online internet hospital with offline medical and imaging centers, all connected through a cloud imaging platform. This structure serves clinicians, patients with specific diseases, physical imaging centers, and AI experts. As of May 2022, Tongxin Zhiyi's services had expanded across 26 provinces in China, serving over 500 imaging centers and medical institutions. The company has received strategic funding from investors including Sequoia and Lake Bleu Capital.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES D✓Equity / VC | May 2022 | $14M | $55M | Bojian Capital · Bojia Capital · China Merchants Capital | ↗ |
Growth signals
Latest recorded traffic for Tongxin Zhiyi is 140 monthly website visits, down 12.5% over the last three months.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Tongxin Zhiyi in the Haidian ecosystem
The Tongxin Zhiyi office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
- BCBojian Capital
Bojia Capital- CCChina Merchants Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Tongxin Zhiyi on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tongxin Zhiyi’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.